Scientists uncover the structure of a protein complex linked with breast and ovarian cancer risk

January 11, 2017
Scientists uncover the structure of a protein complex linked with breast and ovarian cancer risk
Molecular scissors: in the background are DNA-damage foci, each red blob represents a single double-stranded break site in the genome. Credit: The Francis Crick Institute

Scientists at the Francis Crick Institute have described the molecular structure of a key tumour suppressor protein and provided insights into its role in cells.

BRCA1 is a human gene which produces the tumour suppressor protein of the same name. Mutations in BRCA1 can result in a 65-75% lifetime probability of developing breast cancer, and members of families at high risk of can be screened for mutations in the BRCA1 and related BRCA2 genes.

The BRCA1 protein has a key protective role in DNA repair and so helps to maintain genetic stability.

Mutations in the BRCA1 gene which result in insufficient or defective production of the BRCA1 protein will inhibit DNA repair and lead to genetic instability. This increases the likelihood of cancer-causing mutations.

The BRCA1 protein functions in interaction with three protein complexes (BRCA1-A, BRCA1-B and BRCA1-C).

Scientists at the Francis Crick Institute have described the of BRCA1-A and provided insights into its role in deubiquitination, an essential process involved in modulating DNA repair.

The scientists used a range of cutting-edge techniques, including , mass spectrometry and biochemical analysis. Electron microscopy was used to define the overall shape of the protein complex, but this was not sufficient to pin-point the exact locations of the individual molecular components.

A combination of native and was then used to provide the extra information required to triangulate the location of the components.

In the longer term, it is hoped that a more detailed understanding of the structure and function of the complex might inform efforts to develop inhibitors of the BRCA1-A and linked complexes which might be clinically useful.

Steve Smerdon, Group Leader at the Francis Crick and final author on the paper, said: "The structure, albeit at low resolution, is really the first structural glimpse of any of the major BRCA1 complexes. In a way, the size and complexity is somewhat surprising since the reaction it catalyses is relatively simple: the cleavage of a single bond between two linked ubiquitins. The structure now suggests how the overall architecture might act to stabilise interactions with ubiquitin chains. More importantly it also indicates how interaction with BRCA1 itself might regulate its activity."

The paper, Three-dimensional architecture of the human BRCA1-A histone deubiquitinase core complex, is published in Cell Reports.

Explore further: Research explains the role of the gene BRCA1 in DNA repair

More information: Otto J.P. Kyrieleis et al. Three-Dimensional Architecture of the Human BRCA1-A Histone Deubiquitinase Core Complex, Cell Reports (2016). DOI: 10.1016/j.celrep.2016.11.063

Related Stories

Research explains the role of the gene BRCA1 in DNA repair

May 30, 2016
Scientists at the University of Birmingham are a step closer to understanding the role of the gene BRCA1. Changes in this gene are associated with a high risk of developing breast and ovarian cancer.

BRCA1 mutations in breast and ovarian cancer can predict treatment resistance

July 25, 2016
Mutations in the BRCA1 gene are one of the most common risk factors for breast and ovarian cancers. Although tumors that harbor BRCA1 mutations initially respond well to cancer treatments, many tumors eventually become less ...

Early first cancer in BRCA1/2 ups risk in opposite breast

December 30, 2015
(HealthDay)—BRCA1/2 mutation carriers have increased risk of contralateral breast cancer (CBC), with age at first diagnosis a significant predictor of CBC risk, according to a study published online Dec. 23 in the Journal ...

New insights reported about the Angelina Jolie gene

March 4, 2016
Scientists from the Cancer Therapy & Research Center (CTRC) in San Antonio today (March 4) published work that provides deeper insight into how the Angelina Jolie gene, BRCA1, functions in normal breast tissue and how its ...

Researchers uncover novel role of BRCA1 in regulating the survival of skin stem cells

January 3, 2013
Our DNA, which stores our genetic information, is constantly exposed to damage. If not properly repaired, DNA damage can lead to cell death. This, in turn, can lead to tissue exhaustion and ageing, or induce mutations resulting ...

Recommended for you

Whole food diet may help prevent colon cancer, other chronic conditions

September 21, 2017
A diet that includes plenty of colorful vegetables and fruits may contain compounds that can stop colon cancer and inflammatory bowel diseases in pigs, according to an international team of researchers. Understanding how ...

New kinase detection method helps identify targets for developing cancer drugs

September 21, 2017
Purdue University researchers have developed a high-throughput method for matching kinases to the proteins they phosphorylate, speeding the ability to identify multiple potential cancer drug targets.

Poliovirus therapy induces immune responses against cancer

September 20, 2017
An investigational therapy using modified poliovirus to attack cancer tumors appears to unleash the body's own capacity to fight malignancies by activating an inflammation process that counter's the ability of cancer cells ...

Scientists restore tumor-fighting structure to mutated breast cancer proteins

September 20, 2017
Scientists at the Virginia Tech Carilion Research Institute have successfully determined the full architecture of the breast cancer susceptibility protein (BRCA1) for the first time. This three-dimensional information provides ...

Brain cancer growth halted by absence of protein, study finds

September 20, 2017
The growth of certain aggressive brain tumors can be halted by cutting off their access to a signaling molecule produced by the brain's nerve cells, according to a new study by researchers at the Stanford University School ...

New clinical trial explores combining immunotherapy and radiation for sarcoma patients

September 20, 2017
University of Maryland School of Medicine researchers are investigating a new approach to treat high-risk soft-tissue sarcomas by combining two immunotherapy drugs with radiation therapy to stimulate the immune system to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.